Source: Annual Congress 2004 - CPAP therapy for OSA
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
P. E. Brander, J. T. Lehto, A. M. Lindroth, T. S. Lahtinen (Hyvinkää, Finland). Nasopharyngeal symptoms do not increase during nasal CPAP treatment. Eur Respir J 2004; 24: Suppl. 48, 3505

Member's Comments

No comment yet.

Related content which might interest you: Nasopharyngeal symptoms do not predict poor adherence to nCPAP treatment Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Initial acceptance and compliance to nasal CPAP in elderly patients Source: Annual Congress 2009 - Sleep apnoea across the ages Year: 2009 Effect of CPAP on nasal resistance Source: Eur Respir J 2004; 24: Suppl. 48, 573s Year: 2004 Nasal budesonide ameliorates symptoms and polysomnography findings in children with chronic nasal obstruction and mild sleep-disordered breathing Source: Eur Respir J 2003; 22: Suppl. 45, 391s Year: 2003 Effect of heated humidification and topical steroids on compliance, nasal symptoms and quality of life in patients with obstructive sleep apnoea syndrome using nasal continuous positive airway pressure Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006 Initiation of nasal CPAP therapy without a preceding sleep study? Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009 Tolerability on nasal mucociliary clearance after long-term nCPAP treatment in severe OSAS patients Source: Eur Respir J 2001; 18: Suppl. 33, 418s Year: 2001 Nasal vs. oronasal mask: a real-life analysis in adults undergoing auto-adjusting CPAP titration. Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Alternatives for OSAHS treatment: selection of patients for upper airway surgery and oral appliances Source: Eur Respir Rev 2007; 16: 132-145 Year: 2007 Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 CPAP increases bronchial reactivity in OSAS patients Source: Eur Respir Rev 2008; 17: 101-102 Year: 2008 CPAP increases bronchial reactivity in OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Nasal CPAP in the therapy of OSAS – does a closer patient guidance and support increase compliance? Source: Eur Respir J 2005; 26: Suppl. 49, 707s Year: 2005 Compliance of positive airway pressure therapy in patients with sleep related breathing disorder Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Impact of biologic therapy in severe asthma with nasal polyps Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Optimal positive airway pressure predicts oral appliance response to sleep apnoea Source: Eur Respir J 2010; 35: 1098-1105 Year: 2010 Successful treatment of severe laryngomalatia with nasal CPAP in an infant: an experience in Serbia-Montenegro Source: Eur Respir J 2006; 28: Suppl. 50, 184s Year: 2006 Measurement of snoring and stertor using the Sonomat to assess effectiveness of upper airway surgery in children Source: Sleep and Breathing Conference 2021 Year: 2021